Melanoma miRNA trafficking controls tumour primary niche formation

Melanoma originates in the epidermis and becomes metastatic after invasion into the dermis. Prior interactions between melanoma cells and dermis are poorly studied. Here, we show that melanoma cells directly affect the formation of the dermal tumour niche by microRNA trafficking before invasion. Melanocytes, cells of melanoma origin, are specialized in releasing pigment vesicles, termed melanosomes. In melanoma in situ, we found melanosome markers in distal fibroblasts before melanoma invasion. The melanosomes carry microRNAs into primary fibroblasts triggering changes, including increased proliferation, migration and pro-inflammatory gene expression, all known features of cancer-associated fibroblasts (CAFs). Specifically, melanosomal microRNA-211 directly targets IGF2R and leads to MAPK signalling activation, which reciprocally encourages melanoma growth. Melanosome release inhibitor prevented CAF formation. Since the first interaction of melanoma cells with blood vessels occurs in the dermis, our data suggest an opportunity to block melanoma invasion by preventing the formation of the dermal tumour niche.

[1]  D. Elder,et al.  Melanoma-stroma interactions: structural and functional aspects. , 2002, The Lancet. Oncology.

[2]  E. Sahai,et al.  Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. , 2009, Cancer research.

[3]  S. Mathivanan,et al.  ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.

[4]  V. Hearing,et al.  Physiological factors that regulate skin pigmentation , 2009, BioFactors.

[5]  R. Bentley,et al.  M6P/IGF2 receptor: a candidate breast tumor suppressor gene. , 1996, Oncogene.

[6]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[7]  A. Gelber,et al.  CLINICAL PRACTICE Exercises in Clinical Reasoning More than Skin Deep , 2013 .

[8]  Yunyan Shi,et al.  Gastric Cancer Exosomes Trigger Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts through TGF-β/Smad Pathway , 2012, PloS one.

[9]  S. Rai,et al.  Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes , 2012, PloS one.

[10]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[11]  J. Erler,et al.  Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling , 2013, Molecular Cancer Research.

[12]  J. Pawelek,et al.  Why do melanomas get so dark? , 2009, Experimental dermatology.

[13]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[14]  A. Alavi,et al.  Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth Phase , 2000, Annals of Surgical Oncology.

[15]  G. Gabbiani,et al.  Mechanisms of myofibroblast activity and phenotypic modulation. , 1999, Experimental cell research.

[16]  M. Herlyn,et al.  Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.

[17]  T. Walsh,et al.  Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. , 1997, British Journal of Cancer.

[18]  D. Schadendorf,et al.  Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma , 2009, Clinical Cancer Research.

[19]  Ming Yi,et al.  The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts , 2010, Cell cycle.

[20]  M. Gottesman,et al.  Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Lengyel,et al.  MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.

[22]  James W. Clancy,et al.  Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. , 2012, Genes & development.

[23]  L. Larue,et al.  Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines , 2015, Pigment cell & melanoma research.

[24]  J. Fox,et al.  Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. , 2005, Cancer research.

[25]  J. Shabanowitz,et al.  Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. , 2003, Journal of proteome research.

[26]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[27]  Michael S. Goldberg,et al.  Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1. , 2014, The Journal of investigative dermatology.

[28]  Wing‐Leung Wong,et al.  A molecular fluorescent dye for specific staining and imaging of RNA in live cells: a novel ligand integration from classical thiazole orange and styryl compounds. , 2015, Chemical communications.

[29]  R. Silver,et al.  Thrombin Differentiates Normal Lung Fibroblasts to a Myofibroblast Phenotype via the Proteolytically Activated Receptor-1 and a Protein Kinase C-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[30]  R. Boissy Melanosome transfer to and translocation in the keratinocyte , 2003, Experimental dermatology.

[31]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[32]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[33]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[34]  S. Majid,et al.  MicroRNA‐mediated regulation of melanoma , 2014, The British journal of dermatology.

[35]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[36]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[37]  Carmit Levy,et al.  The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA , 2011, Pigment cell & melanoma research.

[38]  Graça Raposo,et al.  Melanosomes — dark organelles enlighten endosomal membrane transport , 2007, Nature Reviews Molecular Cell Biology.

[39]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[40]  V. Hearing,et al.  Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released protein , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  I. Sato,et al.  NADH dehydrogenase activity and expression of mRNA of complex I (ND1, 51kDa, and 75kDa) in heart mitochondria of klotho mouse. , 2005, Okajimas folia anatomica Japonica.

[42]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[43]  Arnold I. Caplan,et al.  Fibroblast heterogeneity: more than skin deep , 2004, Journal of Cell Science.

[44]  A. Yoshimura,et al.  Mutation analysis of the gene encoding the human mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in human cell lines resistant to growth inhibition by transforming growth factor beta(1) (TGF-beta(1)). , 2000, Lung cancer.

[45]  J. Hoheisel,et al.  Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. , 2010, Journal of proteome research.

[46]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[47]  M. Picardo,et al.  Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-associated Kinase, a regulator of cathepsins maturation. , 2014, Cellular signalling.

[48]  Miquel Pons,et al.  Liposomes obtained by the ethanol injection method , 1993 .

[49]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[50]  F. García-Cánovas,et al.  Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. , 1993, The Biochemical journal.

[51]  N. Joshi,et al.  Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. , 2007, Pigment cell research.

[52]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[53]  B. Sander,et al.  Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. , 2007, Free radical biology & medicine.

[54]  J. Drijfhout,et al.  Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. , 2011, The Journal of investigative dermatology.

[55]  D. Sprinzak,et al.  Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF. , 2015, Molecular cell.

[56]  Y. Sidi,et al.  Aberrations in the micro‐RNA biogenesis machinery and the emerging roles of micro‐RNAs in the pathogenesis of cutaneous malignant melanoma , 2012, Pigment cell & melanoma research.

[57]  Daniel Öhlund,et al.  Fibroblast heterogeneity in the cancer wound , 2014, The Journal of experimental medicine.

[58]  Jun S. Song,et al.  Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. , 2010, Molecular cell.

[59]  T. Geiger,et al.  Tumor-derived osteopontin reprograms normal mammary fibroblasts to promote inflammation and tumor growth in breast cancer. , 2015, Cancer research.

[60]  Jun S. Song,et al.  Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes , 2010, Cell.

[61]  M. Herlyn,et al.  Fibroblasts contribute to melanoma tumor growth and drug resistance. , 2011, Molecular pharmaceutics.

[62]  Mikko Koski,et al.  Chipster: user-friendly analysis software for microarray and other high-throughput data , 2011, BMC Genomics.

[63]  M. Ellis,et al.  The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene , 1998, Breast Cancer Research and Treatment.

[64]  M. Karnovsky,et al.  A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy , 1965 .

[65]  N. Erez,et al.  From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation , 2013, The Journal of pathology.

[66]  Wei Shi,et al.  BeadArray Expression Analysis Using Bioconductor , 2011, PLoS Comput. Biol..

[67]  M. Herlyn,et al.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Moura,et al.  Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB1 receptors: a keratinocyte-dependent effect , 2011, Archives of Dermatological Research.